Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression
Year: 2024
Type: article
Source: Inflammopharmacology
Authors: Parviz Soufivand, Ghazal Hosseini Torshizi, Seyed Askar Roghani, Mohammad Dastbaz, Ramin Lotfi, Bijan Soleymani, Fatemeh Heydarpour, Zahra Abdan, Hosna Allahyari
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G8971269394
OpenAlex ID: W4402217543
